Literature DB >> 1559046

The study of transitions in the route of drug use: the route from one route to another.

J Strang1, D C Des Jarlais, P Griffiths, M Gossop.   

Abstract

Route of administration of various drugs is an area of study to which specific attention must be paid in study of different HIV risks of drug use by various routes. If changes in route are seen in individuals or within populations, then study of these transitions in route may identify new approaches which could be developed in HIV prevention. The consideration in this paper is based around ten questions: (i) What is a transition? (ii) Do routes of administration vary by time and place? (iii) Is choice of route influenced by availability of drug paraphernalia? (iv) How does the context influence initial choice of administration, and possible subsequent transitions? (v) Are lapse and relapse meaningful concepts? (vi) Transitions: how much of it is going on? (vii) How much does change of route (with the same drug) signify a change of drug effect, its significance, or its relationship with other risk behaviour? (viii) Is change of route of use of one drug always accompanied by the same change of route of other drugs? (ix) Injectors/non-injectors and sharers/non-sharers: do these behavioural characteristics exist as categories or are they distributed along a continuum? (x) Are transitions reversible? This paper is accompanied by two research reports which describe explorations into the extent and nature of transitions amongst heroin users.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559046     DOI: 10.1111/j.1360-0443.1992.tb01948.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  19 in total

1.  Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Mollie E Patrick; Sarah H Heil; Stephen T Higgins; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2013-08-30       Impact factor: 4.492

2.  Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.

Authors:  April M Young; Jennifer R Havens
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

4.  The AIDS epidemic among Spanish drug users: a birth cohort-associated phenomenon.

Authors:  J Castilla; M Pollán; G López-Abente
Journal:  Am J Public Health       Date:  1997-05       Impact factor: 9.308

5.  Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective.

Authors:  Jesús Sánchez; Dale D Chitwood; Dixie J Koo
Journal:  J Urban Health       Date:  2006-09       Impact factor: 3.671

6.  Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study.

Authors:  Robert G Carlson; Ramzi W Nahhas; Silvia S Martins; Raminta Daniulaityte
Journal:  Drug Alcohol Depend       Date:  2016-01-04       Impact factor: 4.492

Review 7.  HIV prevention among injecting drug users: responses in developing and transitional countries.

Authors:  A L Ball; S Rana; K L Dehne
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

8.  Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.

Authors:  April M Young; Jennifer R Havens; Carl G Leukefeld
Journal:  Harm Reduct J       Date:  2010-10-15

9.  Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users.

Authors:  Kelly E Dunn; Frederick S Barrett; Evan S Herrmann; Jennifer G Plebani; Stacey C Sigmon; Matthew W Johnson
Journal:  Drug Alcohol Depend       Date:  2016-08-25       Impact factor: 4.492

10.  New injectors and the social context of injection initiation.

Authors:  Alex Harocopos; Lloyd A Goldsamt; Paul Kobrak; John J Jost; Michael C Clatts
Journal:  Int J Drug Policy       Date:  2008-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.